Literature DB >> 2859941

[Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin with prolonged action on vertebrate chromatophores.

M E Hadley, J H Mieyr, B E Martin, A M Castrucci, V J Hruby, T K Sawyer, E A Powers, K R Rao.   

Abstract

The in vitro and in vivo responses of integumental chromatophores to alpha-MSH and a related analogue, [Nle4, D-Phe7] -alpha-MSH, were studied in a number of vertebrate species: the teleost, Lebistes reticulatus; the amphibians, Rana pipiens, R. catesbeiana, Xenopus laevis, Bufo alvarius, and B. cognatus; the lizard, Anolis carolinensis; the rattlesnake, Crotalus atrox. The alpha-melanotropin analogue was a superpotent agonist in the in vitro frog (R. pipiens, R. catesbeiana) and lizard (A. carolinensis) skin bioassays. In all species studied, the analogue exhibited ultraprolonged melanotropic activity, both in vitro and in vivo. This melanotropin and related analogues should prove useful in the study of numerous physiological processes, particularly when prolonged melanotropic activity is desired.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859941     DOI: 10.1016/0300-9629(85)90259-2

Source DB:  PubMed          Journal:  Comp Biochem Physiol A Comp Physiol        ISSN: 0300-9629


  3 in total

1.  Pharmacologic response of a controlled-release PLGA formulation for the alpha-melanocyte stimulating hormone analog, Melanotan-I.

Authors:  R Bhardwaj; M E Hadley; R T Dorr; K Dvorakova; C Brooks; J Blanchard
Journal:  Pharm Res       Date:  2000-05       Impact factor: 4.200

2.  Toxicologic studies of a superpotent alpha-melanotropin, [Nle4, D-Phe7]alpha-MSH.

Authors:  R T Dorr; B V Dawson; F al-Obeidi; M E Hadley; N Levine; V J Hruby
Journal:  Invest New Drugs       Date:  1988-12       Impact factor: 3.850

3.  Biochemical regulation of pigment motility in vertebrate chromatophores: a review of physiological color change mechanisms.

Authors:  Russell A Ligon; Kristen L McCartney
Journal:  Curr Zool       Date:  2016-04-19       Impact factor: 2.624

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.